JPWO2023054292A1 - - Google Patents

Info

Publication number
JPWO2023054292A1
JPWO2023054292A1 JP2022565717A JP2022565717A JPWO2023054292A1 JP WO2023054292 A1 JPWO2023054292 A1 JP WO2023054292A1 JP 2022565717 A JP2022565717 A JP 2022565717A JP 2022565717 A JP2022565717 A JP 2022565717A JP WO2023054292 A1 JPWO2023054292 A1 JP WO2023054292A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022565717A
Other versions
JP7236065B1 (ja
JPWO2023054292A5 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/035803 external-priority patent/WO2023054292A1/ja
Application granted granted Critical
Publication of JP7236065B1 publication Critical patent/JP7236065B1/ja
Publication of JPWO2023054292A1 publication Critical patent/JPWO2023054292A1/ja
Publication of JPWO2023054292A5 publication Critical patent/JPWO2023054292A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022565717A 2021-09-28 2022-09-27 トリアジン誘導体を含有する医薬組成物 Active JP7236065B1 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
JP2021157929 2021-09-28
JP2021157929 2021-09-28
JP2021171725 2021-10-20
JP2021171725 2021-10-20
JP2022000723 2022-01-05
JP2022000723 2022-01-05
JP2022015035 2022-02-02
JP2022015035 2022-02-02
JP2022131590 2022-08-22
JP2022131590 2022-08-22
PCT/JP2022/035803 WO2023054292A1 (ja) 2021-09-28 2022-09-27 トリアジン誘導体を含有する医薬組成物

Publications (3)

Publication Number Publication Date
JP7236065B1 JP7236065B1 (ja) 2023-03-09
JPWO2023054292A1 true JPWO2023054292A1 (ja) 2023-04-06
JPWO2023054292A5 JPWO2023054292A5 (ja) 2023-09-06

Family

ID=85476839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022565717A Active JP7236065B1 (ja) 2021-09-28 2022-09-27 トリアジン誘導体を含有する医薬組成物

Country Status (4)

Country Link
JP (1) JP7236065B1 (ja)
KR (1) KR20240082359A (ja)
AU (1) AU2022353486A1 (ja)
CA (1) CA3233206A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7273455B1 (ja) * 2022-01-19 2023-05-15 塩野義製薬株式会社 新型コロナウイルス感染症治療用医薬

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1053230A1 (en) * 1998-01-13 2000-11-22 Scriptgen Pharmaceuticals, Inc. Triazine antiviral compounds
MX2011008362A (es) 2009-02-13 2011-08-24 Shionogi & Co Derivado novedoso de triazina y composicion farmaceutica que comprende el mismo.
CA2807947C (en) 2010-08-10 2018-06-19 Shionogi & Co., Ltd. Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity
WO2013089212A1 (ja) 2011-12-15 2013-06-20 塩野義製薬株式会社 置換トリアジン誘導体およびそれらを含有する医薬組成物
TWI637949B (zh) 2013-06-14 2018-10-11 塩野義製藥股份有限公司 胺基三衍生物及含有其等之醫藥組合物
JPWO2019087884A1 (ja) * 2017-10-31 2020-11-19 富士フイルム株式会社 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー
CN114641485A (zh) 2020-04-05 2022-06-17 辉瑞大药厂 用于治疗covid-19的化合物和方法
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds
EP4282420A1 (en) * 2021-01-20 2023-11-29 National University Corporation Hokkaido University Anti-viral agent
WO2022212314A1 (en) * 2021-03-29 2022-10-06 Shireen Nature Company For General Trading, Ltd. Willow extract and its use in treating coronavirus infection, inflammation, and associated medical conditions
WO2022138988A1 (ja) * 2021-04-14 2022-06-30 塩野義製薬株式会社 ウイルス増殖阻害作用を有するトリアジン誘導体およびそれらを含有する医薬組成物

Also Published As

Publication number Publication date
JP7236065B1 (ja) 2023-03-09
AU2022353486A1 (en) 2024-05-02
KR20240082359A (ko) 2024-06-10
CA3233206A1 (en) 2023-04-06

Similar Documents

Publication Publication Date Title
BR112023005462A2 (ja)
JPWO2022158528A1 (ja)
BR112023012656A2 (ja)
BR112021014123A2 (ja)
BR112022024743A2 (ja)
BR102021018859A2 (ja)
BR112022009896A2 (ja)
BR112023011738A2 (ja)
BR112023016292A2 (ja)
BR112023004146A2 (ja)
BR112023011610A2 (ja)
BR112023011539A2 (ja)
BR112023008976A2 (ja)
BR112023009656A2 (ja)
BR112023006729A2 (ja)
BR102021020147A2 (ja)
BR102021018926A2 (ja)
BR102021018167A2 (ja)
BR102021017576A2 (ja)
BR102021016837A2 (ja)
BR102021016551A2 (ja)
BR102021016375A2 (ja)
BR102021016200A2 (ja)
BR102021016176A2 (ja)
BR112021017747A2 (ja)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221026

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221026

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A801

Effective date: 20221026

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20221026

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221028

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20221028

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230214

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230214

R150 Certificate of patent or registration of utility model

Ref document number: 7236065

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150